A carregar...
Payers’ Costly Battle Against Cancer
In a classic managed care struggle between cost containment and physician autonomy, health plans’ efforts to rein in the expense of biotech cancer drugs are meeting stiff resistance from oncologists. They staunchly defend their practice of buying such drugs and marking up their prices to cover servi...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioCommunications LLC
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564348/ https://ncbi.nlm.nih.gov/pubmed/23393459 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|